Jereme M Sylvain Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 5 days, 7 hours ago

Jereme M Sylvain has an estimated net worth of at least $10.7 million*, as of Nov. 20, 2024. They own 80,774 shares of DXCM stock. They have sold 34,000 shares of DXCM stock since 2021, for an estimated $4.7 million.

Jereme M Sylvain $DXCM SEC Form 4 Insider Trading

Jereme M Sylvain has filed a total of 15 insider trades in $DXCM since 2021. Their most recent trade was a sale of 3,500 shares, made on Nov 15, 2024. Their largest trade was a sale of 11,661 shares, made on Mar 12, 2024. We estimate that they now own 80,774 shares of $DXCM, worth an estimated $6.0 million.

Insider Trading at $DXCM

There have been a total of 324 insider trades reported at $DXCM since 2021, with 0 shares purchased and 783,247 shares sold. The most active insider traders in $DXCM stock have been Kevin R Sayer, Steven Robert Pacelli, and Andrew K Balo. The most recent trade was a sale of 4,259 shares reported by Sadie Stern (EVP, Chief HR Officer), made on Nov 20, 2024.

History of Insider Stock Trades by Jereme M Sylvain

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
DXCM	Sale	3,500	Nov 15, 2024	Nov. 18, 2024, 5:12 p.m.
DXCM	Sale	746	Sep 09, 2024	Sept. 11, 2024, 7:05 p.m.
DXCM	Sale	745	Jun 10, 2024	June 11, 2024, 6:39 p.m.
DXCM	Sale	11,661	Mar 12, 2024	March 14, 2024, 5:40 p.m.
DXCM	Sale	3,363	Feb 20, 2024	Feb. 21, 2024, 6:48 p.m.
DXCM	Sale	2,734	Jan 16, 2024	Jan. 17, 2024, 7:54 p.m.
DXCM	Sale	1,844	Aug 22, 2023	Aug. 22, 2023, 4:04 p.m.
DXCM	Sale	2,400	May 22, 2023	May 23, 2023, 7:12 p.m.
DXCM	Sale	2,400	Feb 22, 2023	Feb. 22, 2023, 7:08 p.m.
DXCM	Sale	2,400	Nov 21, 2022	Nov. 22, 2022, 7:25 p.m.
DXCM	Sale	600	Jun 06, 2022	June 6, 2022, 4:52 p.m.
DXCM	Sale	600	Mar 04, 2022	March 4, 2022, 8:02 p.m.
DXCM	Sale	600	Dec 06, 2021	Dec. 6, 2021, 8:16 p.m.
DXCM	Sale	402	Sep 09, 2021	Sept. 12, 2021, 8 p.m.
DXCM	Sale	5	Sep 09, 2021	Sept. 12, 2021, 8 p.m.

$DXCM Executives and Stock Owners with Insider Trades

Kevin R Sayer, Chairman, CEO & President
Steven Robert Pacelli, Managing Dir., Dexcom Ventures
Andrew K Balo, *
Steven Robert Pacelli, EVP Managing Director Dexcom V
Quentin S. Blackford, Chief Operating Officer
Michael Jon Brown, EVP Chief Legal Officer
Shelly Ramasamy Selvaraj, SVP Information Technology
Jereme M Sylvain, EVP Chief Financial Officer
Sadie Stern, EVP Chief Human Resources Offi
Sadie Stern, EVP Chief Human Resources
Kevin R Sayer, President CEO and Chairman of
Kevin R Sayer, President CEO and Chairman
Barry J. Regan, EVP Operations
Jacob Steven Leach, EVP Chief Technology Officer
Chad Patterson, EVP, Global Marketing
Matthew Vincent Dolan, SVP Corporate Strategy-Develop
Sumi Shrishrimal, SVP Chief Risk Officer
Jereme M Sylvain, EVP, Chief Financial Officer
Patrick Michael Murphy, EVP, Chief Legal Officer
Matthew Vincent Dolan, EVP Strategy & Corp Dev
Shelly Ramasamy Selvaraj, SVP Chief Information Officer
Jacob Steven Leach, EVP Chief Operating Officer
Paul R Flynn, EVP Global Revenue
Paul R Flynn, EVP, Global Revenue
Sadie Stern, EVP, Chief HR Officer
Sadie Stern, EVP Chief Human Resources Off
Matthew Vincent Dolan, EVP Strategy and Corporate Dev
Michael Jon Brown, EVP, Chief Legal Officer
Jereme M Sylvain, EVP, Chief Financal Officer
Donald Abbey, EVP Quality and Regulatory Aff
Sadie Stern, EVP Chief HR Officer
Barry J. Regan, EVP Global Operations
Matthew Vincent Dolan, EVP Strategy and Corporate
Kevin R Sayer, President, CEO and Chairman
Jacob Steven Leach, EVP, Chief Operating Officer
Girish Naganathan, EVP Chief Technology Officer
Chad Patterson, EVP Global Marketing
Teri L Lawver, EVP Chief Commercial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.